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Abstract
The interdependence of selective cues during development of regulatory T cells (Treg cells)
in the thymus and their suppressive function remains incompletely understood. Here, we
analyzed this interdependence by taking advantage of highly dynamic changes in expres-
sion of microRNA 181 family members miR-181a-1 and miR-181b-1 (miR-181a/b-1) during
late T-cell development with very high levels of expression during thymocyte selection,
followed by massive down-regulation in the periphery. Loss of miR-181a/b-1 resulted in inef-
ficient de novo generation of Treg cells in the thymus but simultaneously permitted homeo-
static expansion in the periphery in the absence of competition. Modulation of T-cell
receptor (TCR) signal strength in vivo indicated that miR-181a/b-1 controlled Treg-cell for-
mation via establishing adequate signaling thresholds. Unexpectedly, miR-181a/b-1–defi-
cient Treg cells displayed elevated suppressive capacity in vivo, in line with elevated levels
of cytotoxic T-lymphocyte–associated 4 (CTLA-4) protein, but not mRNA, in thymic and
peripheral Treg cells. Therefore, we propose that intrathymic miR-181a/b-1 controls devel-
opment of Treg cells and imposes a developmental legacy on their peripheral function.
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Author summary
T cells are pivotal in orchestrating an adaptive immune response. They are produced in
the thymus and undergo selection processes resulting in elimination of nonfunctional and
self-reactive cells in order to prevent autoimmune disease. One type of T cells, called regu-
latory T cells (Treg cells), is generated either in the thymus or in the periphery through a
process termed agonist selection. Peripheral Treg cells are crucial for the suppression of
unwanted immune responses. However, too much suppressive function of Treg cells can
also impair immune responses directed against tumors. Here, we have analyzed the mech-
anisms that regulate this process and show that a microRNA, miR-181a/b-1, controls de
novo generation of Treg cells by modulating agonist selection. We show that thymic and
peripheral Treg cells deficient in miR-181a/b-1 contain higher levels of the key effector
molecule CTLA-4, and as a consequence, such Treg cells display increased suppressive
capacity. We observe that the expression of miR-181a/b-1 in peripheral Treg cells is much
lower when compared to thymocytes; thus, our study implies that peripheral Treg-cell
effector function is imprinted during intrathymic differentiation.
Introduction
Regulatory T cells (Treg cells) expressing the lineage-defining transcription factor forkhead
box protein P3 (Foxp3) form an integral part of the adaptive immune system and function to
prevent unwanted immune responses [1,2]. Treg cells are generated during T-cell development
in the thymus (thymic [t]Treg cells) as well as via peripheral induction of naive T cells (induced
[i]Treg cells). Development of tTreg cells depends on strong T-cell receptor (TCR) signals [3].
Accordingly, tTreg cells are generated when a TCR of a developing T cell recognizes a self-anti-
gen with high affinity, as has been demonstrated in mouse models transgenic for both a TCR
and its cognate antigen [4,5] and by analysis of polyclonal superantigen-reactive T cells [6,7].
tTreg cells can develop through two distinct precursor (prec) stages. Some Treg-cell precursors
are found within a cluster of differentiation (CD) 4 single-positive (SP) Foxp3−, glucocorticoid-
induced tumor necrosis factor receptor-related protein high (GITRhi), CD25+ population [8].
These cells are the first precursors generated in double transgenic TCR/cognate-antigen mouse
models [9,10]. More recently, an additional CD4SP Foxp3+CD25− Treg-cell precursor has been
described [11]. These cells are phenotypically less mature than tTreg cells, are generated with
similar kinetics as tTreg cells upon induction of T-cell development in vivo, and efficiently
become tTreg cells in vitro and in vivo [10,11]. Generation of both precursors is dependent on
strong TCR signals, although on average, Foxp3+CD25– Treg-cell precursors have received
somewhat weaker signals than their Foxp3−GITRhiCD25+ counterparts [10]. Further differenti-
ation into mature Foxp3+CD25+ tTreg cells is then dependent on γc cytokines [8,10–12]. The
level of TCR signal strength required for tTreg cell generation in comparison to TCR signals
resulting in clonal deletion have not been fully established. Data from a TCR signaling reporter
as well as repertoire studies suggest that signal strength required for tTreg-cell development
overlaps with that inducing clonal deletion in other autoreactive thymocytes [3,13–15]. How-
ever, reduction of major histocompatibility complex (MHC) ligand levels on medullary thymic
epithelial cells rescued autoreactive T cells from clonal deletion but resulted in a concomitant
increase in Treg-cell development, suggesting that at least some tTreg cells are generated
through weaker TCR signals than those inducing clonal deletion [16].
Treg cells suppress T-cell immune responses using multiple molecular mechanisms, includ-
ing consumption of interleukin-2 (IL-2) and production of suppressive cytokines, as well as
Control of Treg cell development and function by miR-181
PLOS Biology | https://doi.org/10.1371/journal.pbio.2006716 March 11, 2019 2 / 27
(grant number SFB738-A7). to AK. The funder had
no role in study design, data collection and
analysis, decision to publish, or preparation of the
manuscript. German Research Foundation (DFG)
(grant number SFB902-B15). to AK. The funder
had no role in study design, data collection and
analysis, decision to publish, or preparation of the
manuscript. German Research Foundation (DFG)
(grant number EXC62 "REBIRTH"). to AK. The
funder had no role in study design, data collection
and analysis, decision to publish, or preparation of
the manuscript. Boehringer Ingelheim Fonds Travel
Grant. to NZ. The funder had no role in study
design, data collection and analysis, decision to
publish, or preparation of the manuscript. Cancer
Research UK (grant number FC001092). to MGG.
The funder had no role in study design, data
collection and analysis, decision to publish, or
preparation of the manuscript. UK Medical
Research Council (grant number MC_UP_1202/11,
FC001092). to MGG. The funder had no role in
study design, data collection and analysis, decision
to publish, or preparation of the manuscript.
Wellcome Trust (grant number FC001092). to
MGG. The funder had no role in study design, data
collection and analysis, decision to publish, or
preparation of the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
Abbreviations: APC, allophycocyanin; BM, bone
marrow; CD4, cluster of differentiation 4; CHX,
cycloheximide; Cre, Cre recombinase; CTLA-4,
cytotoxic T-lymphocyte–associated protein 4; DLR,
Dual-Luciferase Reporter; DP, CD4+CD8+ double
positive; DPSS, diode-pumped solid state; Dusp6,
dual specificity phosphatase 6; EEA1, early
endosome antigen 1; ERT2, tamoxifen-inducible
estrogen receptor 2; FACS, fluorescence-activated
cell scan; FITC, fluorescein isothiocyanate; Foxp3,
forkhead box protein P3; GFP, green fluorescent
protein; GITR, glucocorticoid-induced tumor
necrosis factor receptor-related protein; GM130,
cis-Golgi matrix protein 130; hCD2, human
cluster of differentiation 2; IL, interleukin; Il7r,
interleukin-7 receptor α gene; InduRag1, inducible
recombination-activating gene 1; iNKT, invariant
natural killer T; ITAM, immunoreceptor tyrosine-
based activation motif; iTreg, induced Treg; KO,
knockout; LAMP2, lysosome-associated
membrane protein 2; LAVES, Niedersächsisches
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expression of the coinhibitory receptor cytotoxic T-lymphocyte–associated protein 4 (CTLA-
4) [17,18]. Mice specifically lacking the inhibitory receptor CTLA-4 in Treg cells succumb to
fatal autoimmune disease, indicating that CTLA-4 plays a major role in suppressive function
[19]. It has been proposed that CTLA-4 on Treg cell surfaces acts through capture of the costi-
mulatory ligands CD80 and CD86 on antigen-presenting cells, thereby curtailing full activa-
tion of conventional T cells [20].
MicroRNAs (miRNAs) play a critical role in immune homeostasis and tolerance. Global
loss of miRNAs results in defective development of tTreg cells [21]. However, no individual
miRNA has been demonstrated to control intrathymic generation of Treg cells. miRNA miR-
181a is the most prominently expressed miRNA in double-positive (DP) thymocytes, and it
has been shown in vitro that miR-181a serves as a rheostat for TCR signals in T cells and thy-
mocytes through targeting a combination of tyrosine and dual-specificity phosphatases,
including protein tyrosine phosphatase, nonreceptor type (Ptpn) 11, Ptpn22, and dual specific-
ity phosphatase 6 (Dusp6) [22–24]. Deletion of miR-181a/b-1 in mice resulted in an almost
complete failure in development of invariant natural killer T (iNKT) cells and Mucosal-Associ-
ated Invariant T (MAIT) cells [25–27] due to a defect in thymic agonist selection [26,28]. Fur-
thermore, loss of miR-181a/b-1 caused altered selection of conventional T cells in a TCR
transgenic model with a shift towards positive selection [29]. However, counterintuitively,
miR-181a/b-1−/− mice display increased resistance to experimental autoimmunity, which has
not been fully explained [29].
Here, we tested the hypothesis that miR-181a/b-1 controlled intrathymic development of
Treg cells. De novo production of miR-181a/b-1−/− tTreg cells was impaired because of altered
sensitivity to TCR signals during selection. Generation of Treg cells in the absence of miR-
181a/b-1 resulted in elevated expression of CTLA-4, which penetrated into the periphery
despite the fact that peripheral WT Treg cells express very low amounts of miR-181a. As a con-
sequence, miR-181a/b-1−/− Treg cells had an increased suppressive capacity.
Results
miR-181a/b-1 controls intrathymic Treg-cell development
First, we tested the hypothesis that miR-181a/b-1 might play a role during Treg-cell develop-
ment. Using a recombination activating gene 1–green fluorescent protein (Rag1GFP) knock-in
allele to discriminate between nascent and mature thymus-resident or recirculating Treg cells,
we found that frequencies and absolute numbers of de novo generated Rag1GFP-positive Treg
cells were reduced by 2- to 3-fold in miR-181a/b-1−/− mice when compared to control (ctrl),
indicating that expression of miR-181a/b-1 is required for normal Treg-cell development in
the thymus (Fig 1A). Competitive bone marrow (BM) chimeras with 1:1 mixtures of donor
cells from wild-type (WT) and miR-181a/b-1−/− mice revealed a disadvantage in Treg-cell gen-
eration, but not more immature double-negative and DP as well as CD4SP populations, from
thymocytes of miR-181a/b-1−/− origin, indicating that miR-181a/b-1 controls Treg-cell forma-
tion in a cell-intrinsic manner (Fig 1B and S1A Fig). In order to test how miR-181a/b-1 influ-
enced developmental progression towards Foxp3+CD25+ Treg cells, we analyzed inducible
Rag1 (InduRag1) miR-181a/b-1−/− mice, in which a wave of T-cell development can be
induced by transient initiation of Rag1 gene expression through a tamoxifen-inducible Cre
recombinase (Cre) [30]. At day 7 after Rag1 induction, only a few CD4SP thymocytes were
generated, precluding robust analysis of Treg cell development (S1B and S1C Fig). However,
we noted reduced frequencies of postselection DP thymocytes as well as postselection CD4SP
thymocytes at this time point in miR-181a/b-1−/− mice when compared to ctrls (S1D Fig).
These data support the notion that selection processes are altered in the absence of miR-181a/
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b-1. At day 14 and day 28, frequencies of Treg cells within CD4SP thymocytes were lower in
miR-181a/b-1−/− mice when compared to ctrls (Fig 1C). Consistent with findings at steady
state, these data indicate that Treg-cell formation is less efficient in the absence of miR-181a/b-
1. Next, we analyzed miR-181a/b-1–dependent formation of Foxp3−CD25+ (prec 1b) or
Fig 1. miR-181a/b-1 control intrathymic development of Treg cells. (A) Representative plots, frequencies, and absolute numbers of
TCRβ+CD4+RagGFPhi Treg cells in miR-181–sufficient and deficient mice. Data from 5 independent experiments; each data point represents one
mouse. (B) Competitive BM chimeras. BM cells from miR-181a/b-1+/− (het) or miR-181a/b-1−/− (KO) mice (both CD45.2) were mixed in a 1:1 ratio
with competitor WT BM cells (CD45.1/2) and injected into lethally irradiated WT recipients (CD45.1). Chimeras were analyzed 12 weeks later for the
generation of TCRβ+CD4+Foxp3+ cells in the thymus. Plots are representative of 2 independent experiments with n = 8 for each genotype. Graph shows
ratio of TCRβ+CD4+Foxp3+ cells within test versus competitor populations. Each data point represents an individual mouse. (C) Frequencies of tTreg
cells (TCRβ+CD4+CD25+Foxp3+) and their precs TCRβ+CD4+CD25−Foxp3+ (Ia) and TCRβ+CD4+CD25+Foxp3− (Ib) on d 14 and 28 after initial
induction of Rag1 expression in InduRag1 mice sufficient and deficient for miR-181a/b-1. Depicted data are from 2 independent experiments, with
n = 1–4 for each genotype and time point analyzed. Below, quantification of the experiment presented in (C). (D) Molecular age of miR-181a/b-1 Treg
cells and their precs assessed using Rag1GFP reporter mice. Representative plot and gating strategy (left) and quantification (right). Data from 2
independent experiments, n = 3–4 for each genotype. Statistical analysis was performed using unpaired Student’s t test (A, B), multiple t test (C), and
two-way ANOVA (D, p-values for effect of genotype, ��p = 0.0021, ���p = 0.0002 and ����p< 0.001). Numerical values are available in S1 Data. BM,
bone marrow; CD, cluster of differentiation; d, day; Foxp3, forkhead box protein P3; GFP, green fluorescent protein; hCD2, human CD 2; InduRag1,
inducible recombination-activating gene 1; KO, knockout; miR-181, microRNA-181; prec, precursor; Rag1, recombination-activating gene 1; TCR, T-
cell receptor; Treg cell, regulatory T cell; tTreg cell, thymic Treg cell; WT, wild type.
https://doi.org/10.1371/journal.pbio.2006716.g001
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Foxp3+CD25− (prec 1a) Treg-cell precursors in the InduRag1 model. At day 14 after induction,
both intermediates were present at somewhat similar frequencies in miR-181a/b-1−/− mice
when compared to ctrl, whereas at day 28, we observed reduced frequencies of Foxp3+CD25−
precursors and an accumulation of Foxp3−CD25+ precursors, suggesting that precursor gener-
ation is not restricted by a developmental block (Fig 1C). Taken together, these data indicate
that in the absence of miR-181a/b-1, Treg cells are formed with slower kinetics rather than
being subject to a defined developmental block. Treg-cell development in the thymus follows a
somewhat different course in the absence of a full CD4SP compartment [10]. To account for
such differences, we complemented the analysis of InduRag1 mice by taking advantage of the
Rag1GFP knock-in allele described above to temporally separate Treg-cell development at steady
state. Green fluorescent protein (GFP+) cells were arbitrarily gated into 5 populations based on
different GFP levels, with loss of GFP expression indicating increasing amounts of time since
cessation of Rag gene expression, which occurs in DP thymocytes. Frequencies of precursor 1b
were elevated in GFPhi cells from miR-181a/b-1−/− mice when compared to ctrls. In contrast,
generation of precursor 1a as well as Treg cells was delayed in miR-181a/b-1−/− mice when
compared to ctrls (Fig 1D), which is consistent with data obtained in the InduRag1 model. We
conclude that loss of miR-181a/b-1 results in an overall delay of Treg-cell formation, which is
likely to be initiated prior to the emergence of defined Treg-cell precursors and cannot be com-
pensated for by increased frequencies of Foxp3–CD25+ precursors.
TCR signal strength determines miR-181a/b-1–dependent Treg-cell
development
In order to test whether TCR signal strength differed in thymocytes from miR-181a/b-1−/−
mice, we assessed expression of Nuclear hormone receptor NUR/77 (Nur77) as a surrogate
marker. Of note, miR-181a/b-1−/− DP cells expressed lower levels of Nur77 prior to stimula-
tion when compared to ctrls (Fig 2A). Furthermore, ex vivo stimulation of miR-181a/b-1−/−
DP cells failed to induce WT levels of Nur77, together suggesting that miR-181a/b-1−/− DP
cells received weaker TCR signals and failed to respond to TCR triggering with the same sensi-
tivity as their WT counterparts (Fig 2A). In order to test whether TCR signaling was impaired
prior to Treg-cell generation, we assessed surface expression of CD5, which correlates with
TCR signal strength, on thymocyte subsets [31]. At steady state, total DP thymocytes, the
majority of which have not undergone selection, displayed similar levels of surface CD5 in the
presence and absence of miR-181a/b-1 (Fig 2B). However, CD4SP thymocytes from miR-
181a/b-1−/− mice displayed lower surface levels when compared to ctrls. tTreg cells from either
genotype expressed similar levels of Nur77 transcripts (Fig 2C), together indicating that miR-
181-a/b-1 limits TCR signal strength prior to the emergence of Treg cells.
Next, we took advantage of a system mimicking increased TCR signal strength during
Treg-cell development via inducible nuclear translocation of the Nur77 family member Nr4a2
[32]. BM chimeric mice were generated to carry miR-181a/b-1–deficient or miR-181a/b-1–
sufficient ovalbumin-specific MHC class II-restricted alpha beta (OT-II) TCR transgenic cells
expressing inducible Nr4a2. Transduction with ctrl virus resulted in generation of low fre-
quencies of Treg cells from miR-181a/b-1–sufficient mice, and even fewer Treg cells emerged
from miR-181a/b-1−/− donor BM cells (Fig 2D). Upon activation of Nr4a2, frequencies of Treg
cells generated from miR-181a+/− donors were slightly, albeit not significantly, reduced, sug-
gesting that activation of Nr4a2 promotes a shift towards clonal deletion. In contrast, in the
absence of miR-181a/b-1, Treg-cell development was rescued upon activation of Nr4a2, sup-
porting the hypothesis that limited TCR signal strength accounts for defective Treg-cell differ-
entiation in miR-181a/b-1−/− mice. To corroborate these data, we analyzed chimeric mice
Control of Treg cell development and function by miR-181
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Fig 2. TCR signal strength determines miR-181a/b-1–dependent Treg-cell development. (A) Expression of Nur77 in DP thymocytes in the absence
of miR-181a/b-1. Unstimulated or stimulated (3 h, 37 ˚C, αCD3/CD28 2.5 μg/ml) thymocytes from miR-181a/b-1 het and KO mice were stained for
intracellular Nur77. Plots are representative of 2 independent experiments with n = 3–4 for each genotype. Graphs show frequencies of Nur77-positive
cells for indicated conditions in CD4+CD8α+ DP thymocytes. (B) Reduced CD5 expression in the absence of miR-181a/b-1 mirrors impaired TCR
signaling. Data from 2 independent experiments with n = 8–9 per group. (C) RNA flow-cytometry analysis of the expression ofNr4a1 (encoding
Nur77) by TCRβ+CD4+Foxp3+ tTreg cells. Numbers indicate average MFI ± SD. Data from 2 independent experiments with n = 2–3 per experiment.
(D) Overexpression of Nr4a2 (Nur77 family) rescues development of Treg cells deficient for miR-181a/b-1. LSK cells from OT-II × miR-181a/b-1+/− or
OT-II × miR-181a/b-1–/–mice were sorted and transduced with a retrovirus expressing a chimeric Nr4a2 molecule in which the Nr4a2 LBD is replaced
by that of a mutant human estrogen receptor-α (Nr4a2-ΔLBD-ERT2) or ctrl retrovirus. Cells were injected into lethally irradiated WT recipients, and 7
weeks later, expression of Nr4a2 was induced via tamox administration for 5 consecutive days before analysis. Plots depict frequencies of Treg cells
generated from precursor cells transduced with ctrl vector (upper panels) and from precursors transduced with vector carrying inducible Nr4a2 (lower
panels). Graphs show summary of the results from 2 independent experiments, with n = 3 for each genotype and condition. (E) Less efficient clonal
deletion and Treg-cell formation in the absence of miR-181a/b-1. OT-II × RIPmOVA chimeras were generated after lethal irradiation of RIPmOVA
recipient mice (ctrl: WT/WT; transgenic: tg/WT) and injection of OT-II × miR-181a/b-1+/− or OT-II × miR-181a/b-1−/− BM cells. Mice were analyzed
after 8 weeks. Plots depict frequencies of Vα2+Vβ5+ OVA-specific donor cells in ctrl and tg recipients, which express OVA during negative selection.
Graphs show summary of this analysis (upper panel) and absolute numbers as well as frequencies of Vα2+Vβ5+Foxp3+ Treg cells generated in the
presence or absence of miR-181a/b-1 (lower panels). Data are representative of 2 independent experiments with n = 6–9 for each recipient/donor
combination. Statistical analysis was performed using unpaired Student’s t test (A, C, D). Numerical values are available in S1 Data. BM, bone marrow;
CD, cluster of differentiation; ctrl, control; DP, double positive; ERT2, tamoxifen-inducible estrogen receptor 2; Foxp3, forkhead box protein P3; LBD,
ligand-binding domain; LSK, lineage-negative, stem cell antigen-1-positive, Kit-positive; MFI, mean fluorescence intensity; miR-181, microRNA-181;
Nr4a1, Nuclear receptor subfamily 4 group A member 1; Nur77, Nuclear hormone receptor NUR/77 encoded by Nr4a1; OT-II, ovalbumin-specific
MHC class II-restricted alpha beta TCR; OVA, chicken ovalbumin; prec, precursor; RIPmOVA, rat insulin-promoter–driven membrane-bound
chicken ovalbumin; SP, single positive; tamox, Tamoxifen; TCR, T-cell receptor; tg, transgenic; Treg cell, regulatory T cell; WT, wild type.
https://doi.org/10.1371/journal.pbio.2006716.g002
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generated using OT-II TCR transgenic miR-181a/b-1–sufficient (OT-II-ctrl) or deficient
(OT-II-knockout [KO]) donor cells transferred into RIPmOVA recipients. RIPmOVA mice
express the cognate antigen for the OT-II TCR in the thymus, resulting in clonal deletion of
OT-II TCR transgenic cells as well as generation of low numbers of Treg cells. OT-II-
KO>RIPmOVA chimeras showed lower levels of clonal deletion and generated considerably
lower numbers of Treg cells when compared to OT-II-ctrl>RIPmOVA chimeras (Fig 2E).
OT-II-ctrl>WT as well as OT-II-KO>WT chimeras failed to generate sizeable numbers of
OT-II Treg cells and showed no signs of clonal deletion of OT-II thymocytes. We conclude
that impaired generation of Treg cells in miR-181a/b-1–deficient mice is due to restricted TCR
signal strength during thymic selection.
Homeostatic expansion generates normal Treg-cell numbers in the
periphery of miR-181a/b-1−/− mice
To address potential consequences of impaired tTreg-cell development in the absence of miR-
181a/b-1, we next determined frequencies of Treg cells in the periphery. We did not observe
any differences in frequencies and absolute numbers of peripheral Treg cells in spleens from
miR-181a/b-1−/− mice compared to ctrls (Fig 3A). Consistently, frequencies of recirculating or
thymus-resident (Rag1GFP-negative) Treg cells in the thymus were largely unaffected in the
absence of miR-181a/b-1, but we observed reduced frequencies of Rag1GFP-positive recent thy-
mic emigrants (RTEs) among peripheral Treg cells (S2A and S2B Fig). Equilibration of Treg-
cell numbers in the periphery can occur through homeostatic expansion of tTreg cells or pref-
erential peripheral induction from naive T cells. Spleens of miR-181a/b-1–sufficient and defi-
cient mice contained comparable frequencies of RTEs (TCRβ+Rag1-GFP+) cells, which are
enriched in peripheral Treg cell precursors (S2B Fig) [33]. Furthermore, CD4+CD25− RTEs
from miR-181a/b-1−/− mice did not produce more iTreg cells upon transfer into lymphopenic
interleukin-7 receptor α gene (Il7r)−/− hosts when compared to ctrls, suggesting that Treg-cell
induction is not the primary mechanism to equilibrate peripheral Treg-cell numbers in miR-
181a/b-1−/− mice (S2C Fig). Chimeric mice generated with 1:1 mixtures of miR-181a/b-1−/−
and WT BM showed that miR-181a/b-1−/− Treg cells had a competitive disadvantage in the
periphery when WT Treg cells were present, indicating that niche availability permits homeo-
static expansion of tTreg cells in miR-181a/b-1−/− mice (Fig 3B). This conclusion was sup-
ported by Helios staining and TCR repertoire analysis. Elevated Helios expression has been
associated with Treg-cell activation and proliferation [34]. Comparison of tTreg cells from
miR-181a/b-1–sufficient and deficient mice showed low and similar expression of Helios
between genotypes (Fig 3C). Staining in peripheral lymphoid organs (spleen, subcutaneous
lymph node (scLN), and mesenteric lymph node [mLN]) revealed elevated numbers of Helios+
Treg cells in miR-181a/b-1−/− mice, indicating that in these mice, more Treg cells are in an
activated/proliferative state (Fig 3C).
We predicted that limited de novo generation and increased peripheral expansion resulted
in reduced TCR diversity in peripheral Treg cells in the absence of miR-181a/b-1. Compari-
son of numbers of unique CDR3 sequences as well as calculation of effective number of spe-
cies as a measure for repertoire diversity showed that TCR diversity in peripheral Treg cells
from miR-181a/b-1−/− mice was significantly reduced (Fig 3D and S3A Fig). In contrast, in
the thymus, Treg cells from miR-181a/b-1−/− mice displayed comparable TCR diversity as
their ctrl counterparts (Fig 3E and S3A Fig). Thus, these data indicate that, as a consequence
of less efficient generation, fewer clones egress from the thymus to be available for peripheral
expansion.
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Inefficient intrathymic generation of Treg cells results in a post-
transcriptional increase in CTLA-4 expression
Next, we assessed whether impaired generation in the thymus altered the phenotype of Treg
cells in the absence of miR-181a/b-1. Expression of miR-181a progressively decreases after thy-
mocytes exit the DP stage, with CD4+SP thymocytes and thymic Treg cells expressing 2-fold
and 15-fold lower levels, respectively (Fig 4A). In the periphery, expression of miR-181a was
further reduced to 30-fold and 75-fold lower levels for CD4+ conventional T cells (Tconv) and
Treg cells, respectively, when compared to DP thymocytes. Peripheral miR-181a/b-1−/− Treg
cells showed a virtually identical global gene expression profile to their ctrl counterparts.
Fig 3. Homeostatic expansion generates normal Treg-cell numbers in the periphery of miR-181a/b-1−/− mice. (A) Frequencies and absolute
numbers of splenic Treg cells in Foxp3hCD2 reporter mice crossed to miR-181a/b-1 KO mice. Plots are representative of 6 independent experiments.
Graph shows summary of all experiments, in which each data point represents one mouse. (B) Competitive BM chimeras. BM cells isolated from miR-
181a/b-1+/− (het) or miR-181a/b-1−/− (KO) mice (both CD45.2) were mixed in 1:1 ratio with competitor BM cells, WT (CD45.1/2), and injected into
lethally irradiated WT recipients (CD45.1). Chimeras were analyzed 12 weeks after injection for the generation of TCRβ+CD4+Foxp3+ cells in the spl.
Plots are representative of 2 independent experiments with n = 8 for each genotype. Graph shows ratio of TCRβ+CD4+Foxp3+ cells within tested to
competitive populations. Each data point represents an individual mouse. (C) Higher frequencies of Helios-positive cells in peripheral lymphoid organs
of miR-181a/b-1−/− mice. Representative histograms and plots from 2 independent experiments (n = 6–9 for each genotype) are depicted. Numbers
indicated average MFI or frequencies of positive cells, ±SD. Statistical analysis was performed using unpaired Student’s t test. (D,E) High-throughput
sequencing of TCRα (CDR3 fragment of Vα8–Cα chain) in splenic Treg (D) and tTreg (E) cells sorted from miR-181a/b-1+/− or miR-181a/b-1−/− mice.
Left graph shows number of all unique CDR3 sequences (CDR3). Right graphs show ENS calculated for each sample. Depicted are 4 independent
sequencing experiments; samples from the same experiment are paired. Statistical analysis was performed using paired Student’s t test. Numerical
values are available in S1 Data. BM, bone marrow; CD, cluster of differentiation; comp., competitor; ENS, effective number of species; Foxp3, forkhead
box protein P3; hCD2, human CD2; KO, knockout; MFI, mean fluorescence intensity; miR-181, microRNA-181; mLN, mesenteric lymph node; scLN,
subcutaneous lymph node; spl, spleen; TCR, T-cell receptor; th, thymus; Treg cell, regulatory T cell; tTreg cell, thymic Treg cell; WT, wild type.
https://doi.org/10.1371/journal.pbio.2006716.g003
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Fig 4. Inefficient intrathymic generation of Treg cells results in post-transcriptional increase in CTLA-4
expression. (A) qRT-PCR analysis of miR-181a expression in sorted thymic populations (left graph) and splenic
populations (right graph). Data from 2 independent experiments, with n = 6–7 (pool) for each genotype and one
experiment for tTreg cells and CD4+ Tconv cells, n = 7 (pool). Expression of miR-181a was normalized to the
expression of housekeeping small RNA, snoR412. Linearized ΔCT values are displayed on the graph. Transcriptional
analysis of splenic Treg (B) and tTreg (C) cells. Heat map of signature genes (absolute expression) in miR-181a/b-1+/−
or miR-181a/b-1−/− Treg cells. Columns on the heat map represent 2 individual samples from pooled thymi of 5–7
animals for each genotype. (D) Flow-cytometry analysis of CTLA-4 expression in tTreg and peripheral Treg cells.
Representative histograms of 2 independent experiments (n = 6–9 for each genotype) are depicted. Numbers indicate
average MFI ± SD. Numerical values are available in S1 Data. CD, cluster of differentiation; CTLA-4, cytotoxic T-
lymphocyte–associated protein 4;Dapl1, death-associated protein-like 1; DP, double positive; Egr, early growth
response gene; Eomes, eomesodermin; Foxp3, forkhead box protein P3; Gata, GATA-binding factor; Gpr83, G-
protein-coupled receptor 83; II2ra, interleukin-2 receptor alpha; II2rb, interleukin-2 receptor beta; II10ra, interleukin-
10 receptor alpha; Ikzf, Ikaros zinc finger; Irf4, interferon regulatory factor 4; Itgae, integrin alpha E; Klrg1, killer cell
lectin-like receptor subfamily G member 1; Lef1, lymphoid enhancer-binding factor 1; Lrrc32, leucine-rich repeat
containing 32;Maf, musculoaponeurotic fibrosarcoma oncogene homolog; MFI, mean fluorescence intensity; miR-
181, microRNA-181; mLN, mesenteric lymph node;Nfatc1, nuclear factor of activated T cells c1; Nrp1, neuropilin 1;
Nr4a, Nuclear receptor subfamily 4 group A; qRT-PCR, quantitative reverse-transcription PCR; Rel, homolog to the
oncogen protein of the reticuloendotheliosis virus strain; Rgs16, regulator of G protein signaling 16; Satbl1, special AT-
rich sequence-binding protein-1; scLN, supraclavicular lymph node; snoR412, small nucleolar RNA 412; Socs2,
suppressor of cytokine signaling 2; spl, spleen; Tconv, conventional T; Tgfb1, transforming growth factor beta 1; th,
thymus; Tigit, T-cell immunoreceptor with Ig and ITIM domains; Tnfrsf4, tumor necrosis factor receptor superfamily
member 4; Treg cell, T regulatory cell; tTreg cell, thymic Treg cell; Xbp1, X-box binding protein 1.
https://doi.org/10.1371/journal.pbio.2006716.g004
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Notably, this was also the case for key Treg-cell signature genes (Fig 4B). Comparison of tran-
scriptomes of thymic miR-181a/b-1−/− Treg cells with their WT counterparts also revealed no
significant differences both globally as well as with regard to Treg-cell signature genes (Fig
4C). Given that miRNAs may also act on a post-transcriptional level, we next assessed expres-
sion levels of Treg-cell signature receptors and transcription factors. Peripheral and tTreg cells
from miR-181a/b-1−/− mice showed similar expression levels of most surface receptors and
transcription factors analyzed as WT ctrls (S4A, S4B and S4C Fig). Notably, we detected
strongly increased levels of total CTLA-4 protein in both peripheral and tTreg cells from miR-
181a/b-1−/− mice when compared to ctrls (Fig 4D). Although the coding sequence of Ctla4
mRNA contains putative miR-181 binding sites, direct modulation of CTLA-4 expression by
miR-181 could not be observed in luciferase assays (S5A and S5B Fig).
We conclude from these data that thymic generation in the absence of miR-181a/b-1 results
in post-transcriptionally controlled up-regulation of CTLA-4 protein in Treg cells while other
Treg-cell signature genes remain unaffected. Loss of miR-181a expression in WT peripheral
Treg cells suggests that elevated expression of CTLA-4 in these cells is imprinted during
development.
Elevated levels of CTLA-4 in the absence of miR-181a/b-1 are maintained
via increased rates of translation
In order to understand the underlying mechanisms of how elevated levels of CTLA-4 protein
are maintained in peripheral miR-181a/b-1−/− Treg cells, we analyzed its intracellular distribu-
tion using confocal microscopy. We confirmed elevated expression of CTLA-4 protein in the
absence of miR-181a/b-1 (Fig 5A). Next, we determined intracellular localization of CTLA-4
by costaining for Ras-related in brain protein 11 (Rab11, marking recycling endosomes), lyso-
some-associated membrane protein 2 (LAMP2, late endosomes), early endosome antigen 1
(EEA1, early endosomes), and cis-Golgi matrix protein 130 (GM130, Golgi). We detected no
differences in the extent of colocalization of CTLA-4 with early endosomes and the Golgi appa-
ratus in Treg cells from miR-181a/b-1−/− mice compared to ctrls (Fig 5B). However, we noted
reduced colocalization of CTLA-4 with recycling endosomes but a marked increase in colocali-
zation with late endosomes in miR-181a/b-1−/− Treg cells when compared to ctrls (Fig 5C).
In order to assess whether aberrant localization of CTLA-4 in miR-181a/b-1−/− Treg cells
affected protein degradation, we stimulated Treg cells in the absence or presence of the transla-
tion inhibitor cycloheximide. Inhibition of translation for 2 h reduced CTLA-4 protein to sim-
ilar levels in miR-181a/b-1−/− Treg cells and ctrls (Fig 5D). Given the higher protein levels
when translation is active, these data imply that degradation rates of CTLA-4 are higher in the
absence of miR-181a/b-1, which is consistent with its preferential localization in late endo-
somes rather than recycling endosomes. Furthermore, these data predict that if protein degra-
dation is intact, elevated levels of CTLA-4 protein arise as a result of increased rates of protein
translation. To test this prediction, we assessed accumulation of CTLA-4 protein in Treg cells
in the presence of bafilomycin, an inhibitor of lysosomal protein degradation, in vitro. Over
the course of 3 hours, miR-181a/b-1−/− Treg cells accumulated significantly more CTLA-4 pro-
tein when compared to their WT counterparts (Fig 5E). Together, these data indicate that ele-
vated levels of CTLA-4 in peripheral Treg cells in the absence of miR-181a/b-1 are due to
increased rates of translation. Increased protein translation in the absence of altered mRNA
levels may be induced by loss of miRNAs other than miR-181a/b-1. To test this possibility, we
performed small RNA sequencing (small RNAseq) of miR-181a/b-1–sufficient and deficient
peripheral Treg cells. Consistent with the overall small changes in the transcriptome, we iden-
tified 4 miRNAs (miR-15b, miR-150, miR-342, and lethal (let)-7g) that were moderately
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Fig 5. Elevated levels of CTLA-4 in the absence of miR-181a/b-1 are cell-intrinsically maintained via increased
rates of translation. (A) Immunofluorescence staining of Treg cells from miR-181a/b-1+/− or miR-181a/b-1−/− mice
with antibodies against Foxp3 and CTLA-4. Right panel, quantification of integrated density for CTLA-4 fluorescence
normalized to the area of each individual cell. Data are representative of 3 independent experiments with n = 3 for
each genotype (pooled). Data were analyzed using ImageJ software. DAPI, nuclear staining. Scale bar, 2 μm. (B)
Immunofluorescence staining of CD4+ T cells from miR-181a/b-1+/− or miR-181a/b-1−/− mice with antibodies against
murine CTLA-4, EEA1 (upper panel) and GM130 (lower panel). Data are representative of 3 independent experiments
with n = 3 (pool). Right panels show colocalization scatter plots. (C) Immunofluorescence staining of CD4+T cells
from miR-181a/b-1+/− or miR-181a/b-1−/− mice with antibodies against murine CTLA-4, Rab11 (upper panel) and
LAMP2 (lower panel). Data are representative of 3 independent experiments with n = 3 (pool). Right panels show
colocalization scatter plots. Data were analyzed using ImageJ software. DAPI, nuclear staining. Scale bar, 2 μm. (D)
Enhanced degradation of CTLA-4 in the absence of miR-181a/b-1. CD4+ T cells isolated from spls and subcutaneous
LNs of miR-181a/b-1+/− or miR-181a/b-1−/− mice were stimulated for 2 h with αCD3/αCD28 antibodies. In order to
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down-regulated in Treg cells from miR-181a/b-1−/− mice (S5C and S5D Fig). However, in sil-
ico analysis of Ctla4mRNA using Targetscan7 and RNA22 provided no evidence for the exis-
tence of either canonical or noncanonical binding sites for any of these miRNAs, suggesting
that elevated protein levels of CTLA-4 are not caused by reduced miRNA expression. Next, we
assessed whether peripheral expansion contributed to sustained expression of CTLA-4 in
peripheral Treg cells. To this end, we generated mixed BM chimeras and analyzed CTLA-4 lev-
els on miR-181a/b-1−/− and WT Treg cells isolated from the same mice. CTLA-4 levels were
consistently higher in miR-181a/b-1–deficient Treg cells despite competition by their WT
counterparts, indicating that CTLA-4 levels are regulated cell-intrinsically and do not depend
on peripheral expansion (Fig 5F). Finally, we tested whether alterations in tonic TCR signaling
might result in elevated expression of CTLA-4. Freshly isolated peripheral Treg cells from
miR-181a/b-1−/− and WT mice expressed comparable levels of Nr4a1 mRNA, suggesting that
tonic signaling through the TCR is similar (Fig 5G). Taken together, these findings further
support the hypothesis that miR-181a/b-1–dependent ctrl of CTLA-4 expression is elicited in
the thymus and subsequently sustained in the periphery.
Treg cells from miR-181a/b-1−/− mice display increased suppressive
capacity
In order to test the functional consequences of elevated levels of CTLA-4 in miR-181a/b-1−/−
Treg cells, we assessed their suppressive capacity. First, loss of miR-181a/b-1 resulted in
reduced levels of tumor necrosis factor (TNF)α, IL-4, and IL-2 by conventional CD4+ T cells
(Fig 6A). In contrast, expression of IL-17 and IL-10 remained unaffected. Whereas levels of
TNFα were also reduced in miR-181a/b-1−/− Treg cells, we did not observe additional signifi-
cant miR-181a/b-1–dependent alterations in cytokine production by Treg cells or CD8+ T
cells (Fig 6A and S6A Fig). Such alterations in cytokine profiles might be due to cell-intrinsic
effects or due to modulation of Treg-cell suppressive capacity. Therefore, we next assessed in
vivo suppressive capacity of Treg cells by transfer of congenically marked 1:1 mixtures of miR-
181a/b-1–sufficient or miR-181a/b-1–deficient Treg cells (CD45.2) and conventional T cells
(CD45.1) into Rag1−/− recipients. Suppression of lymphopenia-driven expansion of Tconv
cells is dependent on CTLA-4 [35]. At 14 days after transfer, homeostatic expansion of Tconv
cells was assessed. We observed lower frequencies of Tconv cells (CD45.1) in spleens of mice
monitor protein degradation, CHX was added and incubated with cells for an additional 3 h. Each dot represents an
individual cell from 10–12 randomly chosen fields of view. Quantification of integrated density for CTLA-4
fluorescence per cell was quantified using ImageJ software. (E) CD4+CD25+-enriched T cells were incubated in the
presence of an inhibitor of lysosomal degradation, bafilomycin, for indicated time points. Accumulation of CTLA-4
was detected using FACS, and fold increase of MFI was calculated using time point 0 as reference. Data from 3
independent experiments, n = 3. (F) Cell-intrinsic up-regulation of CTLA-4 in the absence of miR-181a/b-1. Mixed
BM chimeras were generated by mixing BM cells from miR-181a/b-1+/− (CD45.1) and miR-181a/b-1−/− (CD45.2) mice
in a 1:1 ratio and injecting them into lethally irradiated WT recipients (CD45.1/2). Chimeras were analyzed 8 weeks
after reconstitution for CTLA-4 expression in TCRβ+CD4+Foxp3+ cells from the Thy, spl, and LNs. Plots are
representative of 2 independent experiments with n = 9 per experiment. Each set of paired data points represents an
individual mouse. (G) RNA flow-cytometry analysis of the expression of Nr4a1 by TCRβ+CD4+Foxp3+ Treg cells from
pooled spl and LNs. Numbers indicate average MFI ± SD. Data from 2 independent experiments with n = 2–3 per
experiment. Statistical analysis was performed using unpaired Student’s t test (A), two-way ANOVA (E, p-values for
effect of genotype, ��p = 0.0021) and paired Student’s t test (F, p-values for effect of each genotype, ��p = 0.0021,
���p = 0.0002, and ����p< 0.0001). Numerical values are available in S1 Data. AU, arbitrary unit; BM, bone marrow;
CD, cluster of differentiation; CHX, cycloheximide; CTLA-4, cytotoxic T-lymphocyte–associated protein 4; EEA1,
early endosome antigen 1; FACS, fluorescence-activated cell scan; Foxp3, forkhead box protein P3; GM130, cis-Golgi
matrix protein 130; LAMP2, lysosome-associated membrane protein 2; LN, lymph node; MFI, mean fluorescence
intensity; miR-181, microRNA-181;Nr4a, Nuclear receptor subfamily 4 group A; Rab11, Ras-related in brain protein
11; spl, spleen; TCR, T-cell receptor; Thy, thymus; Treg cell, regulatory T cell; WT, wild type.
https://doi.org/10.1371/journal.pbio.2006716.g005
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Fig 6. Treg cells from miR-181a/b-1−/− mice display increased suppressive capacity. (A) Production of cytokines by
splenic CD4+ T cells and Treg cells after stimulation with PMA/ionomycin. Graphs represent quantification of the data
from 3 independent experiments, n = 4–5 for each genotype. (B) In vivo suppression of homeostatic proliferation in
lymphopenic Rag−/− mice by miR-181a/b+/− and miR-181a/b−/− Treg cells. Depicted is expansion of Tconv in the
absence (no Treg cells) and presence of miR-181a/b-1+/− or miR-181a/b-1−/− Treg cells 14 days after coinjection of T
cells. (C) Quantification and absolute numbers of recovered Tconv cells and Treg cells. Data are representative of 2
independent experiments, with n = 7–8 (recipient mice). Statistical analysis was performed using unpaired Student’s t
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co-transferred with miR-181a/b-1−/− Treg cells when compared to those co-transferred with
miR-181-a/b-1–sufficient Treg cells (Fig 6B). This reduction in frequency was reflected by
lower absolute numbers of Tconv cells recovered in the presence of miR-181a/b-1−/− Treg
cells, whereas absolute numbers of Treg cells recovered were similar in both conditions (Fig
6C). Together, these data indicate that in the absence of miR-181a/b-1, Treg cells have a stron-
ger capacity to suppress lymphopenia-driven expansion of Tconv cells in vivo. Of note, we did
not observe significant alterations in suppressive capacity of miR-181a/b-1−/− Treg cells in
vitro (S6B Fig). Taken together, our data indicate that miR-181a/b-1 controls intrathymic Treg
cell development in a TCR-dependent manner. Impaired Treg-cell development in the absence
of miR-181a/b-1 is associated with post-transcriptional up-regulation of CTLA-4, which pene-
trates into the periphery and results in increased suppressive capacity. Low levels of miR-181a
in peripheral WT Treg cells suggest that the effects of loss of miR-181a/b-1 are imprinted dur-
ing intrathymic development.
Discussion
Here, we demonstrated that intrathymic generation of Treg cells depends on miR-181a/b-1 via
establishing signaling thresholds to adequately respond to strong TCR signals. In the absence
of miR-181a/b-1, de novo generation of Treg cells was attenuated and resulted in Treg cells
expressing elevated levels of CTLA-4. Homeostatic expansion resulted in a completely filled
peripheral Treg-cell compartment while CTLA-4 levels remained elevated via a post-transcrip-
tional mechanism, resulting in Treg cells with increased suppressive capacity.
Treg cells develop from CD4SP thymocytes through two possible intermediates,
Foxp3−CD25+ and Foxp3+CD25− [8,11]. It has been suggested that generation of these precur-
sors occurs through a TCR-dependent step, whereas further maturation into mature
Foxp3+CD25+ Treg cells is dependent on the cytokines IL-2 and IL-15 [8,10,11]. Analysis of
InduRag1 mice as well as a Rag1GFP virtual timer indicated that miR-181a/b-1 predominantly
affects formation of Foxp3+CD25− precursors, whereas Foxp3−CD25+ are more frequent in
miR-181a/b-1–deficient mice. Nevertheless, these precursors cannot compensate for the par-
tial loss of Foxp3+CD25− precursors, suggesting that the major route of Treg-cell development
is through the latter. Indeed, it has been shown that in WT mice, only approximately 20% of
CD4+Foxp3−CD25+ cells ultimately give rise to Treg cells [8,10]. Treg-cell development via
Foxp3−CD25+ intermediates predominantly occurs in double transgenic mouse lines express-
ing a transgenic TCR plus its cognate antigen [9]. Furthermore, these cells express higher levels
of a Nur77GFP reporter than either Foxp3+CD25− precursors or mature Treg cells [10]. Thus, it
has been suggested that Foxp3−CD25+ intermediates arise at the extreme end of the TCR affin-
ity spectrum and might increase in frequency by an influx of cells otherwise targeted for clonal
deletion. Accordingly, reduction in MHCII levels on thymic epithelial cells in a monoclonal
system diverted thymocytes from clonal deletion into the Treg cell lineage [16]. TCR repertoire
analyses and autoreactivity suggest that TCR signal strength required for tTreg-cell generation
overlaps both with that of positively selected thymocytes as well as that of cells normally under-
going clonal deletion [3,13,14]. Rescue experiments performed in this study agree with both
non-mutually exclusive models. Fewer donor-derived miR-181a/b-1−/− OT-II Treg cells devel-
oped in RIPmOVA antigen transgenic mice compared to WT OT-II Treg cells. Concomi-
tantly, clonal deletion of miR-181a/b-1−/− OT-II cells was also impaired in RIPmOVA mice,
test. Numerical values are available in S1 Data. CD, cluster of differentiation; IFN-γ, interferon gamma; IL, interleukin;
miR-181, microRNA-181; PMA, phorbol 12-myristate 13-acetate; pos., positive; Tconv, conventional T; TCR, T-cell
receptor; TNF, tumor necrosis factor; Treg cell, regulatory T cell.
https://doi.org/10.1371/journal.pbio.2006716.g006
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suggesting that in this particular paired TCR–antigen model, TCR signal strength is reduced
through loss of miR-181a/b-1 to limit both Treg-cell formation and clonal deletion. Con-
versely, induced expression of Nr4a2 promoted Treg-cell production in the absence of miR-
181a/b-1 but resulted in somewhat limited production of Treg cells in the presence of miR-
181a/b-1, suggesting that in the latter case, clonal deletion might be favored over Treg-cell
development.
Intrathymic development of Treg cells depends on CD28-mediated costimulatory signals
[36]. Thus, it might be possible that elevated expression of CTLA-4 by Treg cells in the thymus
contributes to impaired development. Costimulation via CD28 is required for efficient genera-
tion of Foxp3−CD25+ Treg-cell precursors but less so during later Treg-cell development, sug-
gesting that CD28 signaling protects thymocytes from clonal deletion [36–39]. Loss of CD28
signaling does not result in export of autoreactive cells into the periphery, indicating that it
does not simply act as an amplifier of TCR signal strength [39]. Consistently, loss of CD28-me-
diated costimulation and loss of miR-181a/b-1 generate phenotypically distinct developmental
defects, also supporting the notion that elevated levels of CTLA-4 in miR-181a/b-1−/− Treg
cells are a consequence rather than cause of inefficient generation of Treg cells in these mice.
Consequences of altered TCR signal strength in the thymus have been previously analyzed
in mice carrying hypomorphic mutations of key signal mediators, such as zeta-chain–associ-
ated kinase of 70 kD (Zap-70), or reduced numbers of immunoreceptor tyrosine-based activa-
tion motifs (ITAMs) within CD3z molecules [40–42]. Collectively, these studies showed that
alterations in TCR signal affected positive and negative selection as well as Treg-cell formation,
albeit in a manner that is not easily predictable. Thus, these data indicate that the quantitative
relationship between proximal TCR signaling and effcient thymic selection needs to be tightly
balanced. Furthermore, mutations characterized in these studies equally affect T-cell activation
and tonic signaling in the periphery, precluding analysis of developmental consequences of
altered TCR signaling exclusively occurring in the thymus.
In contrast, expression levels of miR-181a/b-1 in peripheral Treg cells are very low and
should therefore allow WT-like levels of tonic TCR signaling. Notably, peripheral TCR signal-
ing controls Treg-cell homeostasis and helps to maintain functional Treg cells [43,44]. For
instance, in the absence of peripheral TCR expression, levels of CTLA-4 protein are reduced,
and suppressive capacity is compromised [44].
Our data suggest that alterations in thymic selection caused by the absence of miR-181a/b-1
have long-term impact and are translated to increased suppressive activity of peripheral Treg
cells. We therefore propose that the developmental legacy of TCR signal strength during ago-
nist selection determines Treg-cell function in the periphery. Thus, altered TCR thresholds
during selection might affect a Treg cell’s responsiveness to tonic signaling. Similar observa-
tions have previously been reported for both CD4 and CD8 Tconv cells [45,46]. The avidity of
positively selecting self-peptides and thus strength of the TCR signal during selection deter-
mines the outcome of a T-cell immune response even of T cells recognizing the same foreign
antigen with an identical avidity [45]. In contrast to Treg cells, differential reactivity to self-
peptide by CD8 Tconv cells was accompanied by clear differences in gene expression profiles
[46]. Although in Tconv cells, the capacity for tonic signaling in the periphery contributes to
distinct responsiveness to pathogens, thymically predetermined levels of the feedback regula-
tor of TCR signaling CD5 are likely to help control tonic signals [45]. Thus, the quality of pro-
tective T-cell responses as well as Treg-cell mediated suppression appear to be preset during
thymic selection.
How TCR signal strength during thymic agonist selection confers long-term changes in
CTLA-4 protein expression remains unclear. Our study supports a model in which expression
of CTLA-4 is cell-intrinsically sustained in the periphery through a post-transcriptional
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mechanism controlling its translation rate. Translational control can be exerted at multiple dif-
ferent levels, including changes in mRNA composition through alternative splicing and miR-
NAs as well as RNA binding proteins. Given the lack of umambiguous evidence for one of
these mechanisms being predominant, our data suggest that multiple factors may act in con-
cert to control CTLA-4 protein. Tight control of CTLA-4 expression is likely to be paramount
for tuning suppressive capacity of Treg cells.
Our study establishes miR-181a/b-1 as a central regulator of agonist-selected αβT cells. Ear-
lier studies showed that miR-181a/b-1 is critical for the development of innate-like T cells
expressing semi-invariant TCRs, such as iNKT cells and MAIT cells (but not their γδTCR-
expressing counterparts) [25,26,47]. Here, we demonstrated that the role of miR-181a/b-1 can
be extended to highly diverse polyclonal T-cell populations. This finding was not anticipated
because it might be expected that a shift in integrated signal strength might be compensated
for by a shift in the repertoire. Such compensation might partly explain why the effect of miR-
181a/b-1 deletion on Treg cells is somewhat milder when compared to other agonist selected T
cells. Finally, based on the dramatic down-regulation of miR-181a after the DP stage, our
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Regierungspräsidium Darmstadt (V54–19c20/15–FU/1119; FU/1155; FU/1159; FU/1178) or
under a project license granted by the UK Home Office (PPL60_4510 procedure 19b 5),
respectively. Animals were killed by CO2 inhalation, in some cases followed by cervical
dislocation.
Mice
MiR-181a/b-1−/− and miR-181a/b-1+/− mice (B6.Mirc14tm1.1Ankr) were generated as described
in [26] and bred at the Hannover Medical School and Goethe University, Frankfurt, Germany.
OT-II mice (B6.Cg-Tg(TcraTcrb)425Cbn/J) were purchased from The Jackson Laboratory,
crossed with miR-181a/b-1−/− and miR-181a/b-1+/− mice, and bred at the Hannover Medical
School. RIPmOVA mice (C57BL/6-Tg(Ins2-TFRC/OVA)296Wehi/WehiJ) were purchased from
The Jackson Laboratory and crossed with B6 CD45.1. F1 mice (RIPmOVA CD45.1/2) were
bred at the Hannover Medical School. C57BL/6J mice (CD45.2), B6.SJL-PtprcaPepcb/BoyJ
mice (termed “B6 CD45.1” throughout this manuscript), and IL-7Rα–deficient mice
(B6.129S7-Il7rtm1Imx/J) were purchased from Charles River or The Jackson Laboratory or bred
at the animal facility of Hannover Medical School. (C57BL/6J × B6 CD45.1) F1 mice (CD45.1/
CD45.2 heterozygous) and IL-7Rα−/− CD45.1 mice were bred at the animal facility of Hanno-
ver Medical School. InduRag1fl/fl × Rosa26-CreERT2 mice (termed InduRag1 here) were
obtained by crossing InduRag1fl/fl mice with Rosa26-CreERT2 mice (kindly provided by Prof.
Anton Berns, The Netherlands Cancer Institute, Amsterdam, The Netherlands) and bred at
the Helmholtz Centre for Infection Research [30]. These mice were crossed to miR-181a/b-
1−/− (InduRag1 × miR-181a/b-1−/−) and miR-181a/b-1+/− (InduRag1 × miR-181a/b-1+/−) mice
bred and maintained at the Helmholtz Centre for Infection Research in Braunschweig.
Foxp3hCD2 × Rag1GFP mice were obtained by crossing Foxp3hCD2 mice [48] with Rag1GFP
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mice [49] (kindly provided by Nobuo Sakaguchi, Kumamoto, Japan). These mice were crossed
to miR-181a/b-1−/− and miR-181a/b-1+/− mice and bred at the Helmholtz Centre for Infection
Research in Braunschweig. Rag1−/− mice and B6 CD45.1 mice used in the in vivo suppression
assay were bred and maintained at the University of Edinburgh. All mice were used between
7–12 weeks of age and were maintained under specific-pathogen–free conditions.
In vivo induction of Treg-cell development
Treg-cell development was induced in 6- to 8-week–old InduRag1 × miR-181a/b-1−/− and
InduRag1 × miR-181a/b-1+/− mice by oral administration of tamoxifen (Ratiopharm, Ulm,
Germany) in corn oil (Sigma Aldrich, St. Louis, MO, USA), 0.6 mg/400 μl/mouse every 4 days.
To ensure proper tamoxifen solubility, in the first step, it was dissolved in 100% ethanol pre-
warmed to 55 ˚C and later in prewarmed corn oil. Before each oral administration, the mixture
was always prewarmed to 37 ˚C.
Competitive BM chimeras
B6 CD45.1+ recipient mice were lethally irradiated (9 Gy). Donor BM from both WT (CD45.1/
2+) and miR-181a/b-1+/− or miR-181a/b-1−/− (CD45.2+) mice mixed at a 1:1 ratio was injected
into the lateral tail vein within 24 h postirradiation (a total of 4 × 106 cells/mouse). Mice were
provided with antibiotic-containing water and were housed in sterile microisolator cages.
Analysis of BM chimeras was performed 8–12 weeks after transplantation.
Overexpression of Nr4a2 in BM chimeras
BM cells were isolated from the tibia and femur of age-matched (7–10 weeks) OT-II × miR-
181a−/− and OT-II × miR-181a+/− mice. First, lineage-negative (lin−) cells were enriched by
incubation with the cocktail of purified rat-anti-mouse antibodies (CD19 [1D3], CD11b [M1/
70], Gr-1 [RB6-8C5], NK1.1 [PK136], Ter-119, CD4 [RM4.4], and CD8α [53–6.7]; all from
eBioscience, Thermo Fisher Scientific, Waltham, MA, USA) followed by incubation with
sheep-anti-rat dynabeads (Dynal; Invitrogen, Carlsbad, CA, USA) and magnetic separation.
Cells were stained with a phycoerythrin (PE)-Cy7–conjugated cocktail of lin antibodies (CD19
[6D5], CD11b [M1/70], Gr-1 [RB6-8C5], NK1.1 [PK136], Ter-119, CD4 [GK1.5], and CD8α
[53–6.7]; all from eBioscience) and Sca-1 (E13–161.7) PacificBlue, c-kit (CD117) allophyco-
cyanin (APC), and sorted as lin−Sca-1+c-kit+ to 98% purity. Cells were cultured overnight at a
density of 5 × 104 cells/100 μl (on 96-well plate) with mouse IL-6 (20 ng/ml), mouse IL-7 (25
ng/ml), mouse Flt-3L (25 ng/ml), and mouse SCF (50 ng/ml; all obtained from PeproTech,
Rocky Hill, NJ, USA), in DMEM containing 10% FBS. Next day, cells were infected by centri-
fugation at 700 g for 45 min at 32 ˚C on retronectin-coated plates (50 μg/ml, 4 ˚C overnight)
loaded (3× 100 μl/well, 2,000 g, 20 min at 32 ˚C) with Nr4a2-ΔLBD-ERT2–expressing retrovi-
rus or ctrl retrovirus (both carrying Thy1.1 tag detectable by flow ctometry) in the presence of
polybrene (8 μg/ml) and the abovementioned cytokines. Fresh medium was supplemented
after 24 h. After 48 h, cells were collected, and transduction efficacy (frequency of Thy1.1+
cells) was determined. Routinely, it was approximately 60%, and thus cells were later sorted to
100% of Thy1.1+. B6 CD45.2+Thy1.2+ recipient mice were lethally irradiated (9 Gy). Sorted
cells were intravenously injected (1 × 105/recipient). Mice were provided with antibiotic-con-
taining water and were housed in sterile microisolator cages.
Six weeks after injection, mice were orally administered 0.6 mg/400 μl of tamoxifen (Ratio-
pharm) dissolved in corn oil (Sigma Aldrich) per recipient mouse for 5 consecutive days.
Tamoxifen preparation was performed as for induction of Treg-cell development in InduRag1
mice. Twelve hours after the final administration, mice were analyzed.
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Intracellular staining of Nur77 in thymocytes
Thymocytes isolated from miR-181a+/− and miR-181a−/− mice were left untreated or were
stimulated for 3 h at 37 ˚C in the presence of plate-bound αCD3 (17A2, 2.5 μg/ml) and soluble
αCD28 (37.51, 2.5 μg/ml). Next, cells were stained for surface CD4 and CD8α and intracellular
Nur77 with intracellular staining buffer set (eBioscience).
RIPmOVA × OT-II BM chimeras
BM cells were isolated from the tibia and femur of age-matched (7–10 weeks) OT-II × miR-
181a/b-1−/− and OT-II × miR-181a/b-1+/− mice. Red blood cells were lysed, and cells were
counted and injected (5 × 106/recipient) into the lateral tail vein of lethally (2 × 4.5 Gy) irradi-
ated RIPmOVA (CD45.1/2+) recipient mice. Mice were provided with antibiotic-containing
water and were housed in sterile microisolator cages. Analysis of BM chimeras was performed
8–12 weeks after transplantation.
Flow cytometry and cell sorting
Monoclonal antibodies specific for CD4 (RM4.4, GK1.5), CD8α (53–6.7), CD25 (PC61.5,
eBio7D4 for sort), CD24 (M1/69), CD27 (LG.3A10), CD28 (37.51), CD103 (M290), CD122
(TM-β1), CD127 (A7R34), Gr-1 (RB6-8C5), erythroid cell marker (Ter-119), CD19 (1D3,
6D5), CD11b (M1/70), CD45.1 (A20), CD45.2 (104), CD117 (c-kit) (2B8, ACK2), Sca-1 (E13–
161.7), NK1.1 (PK136), CD11c (N418), TCRβ (H57-597), Foxp3 (MF23, FJK-16s), human
CD2 (RPA-2.10), Qa2 (1-1-2), Nur77 (12.14), Vβ5.1/5.2 TCR (MR9-4), Vα2 TCR (B20.1),
CTLA-4 (UC10-4B9, UC10-4F10-11), Helios (22F6), TGF-βR (RI/ALK-5), GITR (DTA-1),
PLZF (Mags.21F7), Gata3 (TWAJ), Egr2 (erongr2), Irf4 (3E4), c-Rel (1RELAH5), and KLRG1
(2F1) were used as biotin, PacificBlue, fluorescein isothiocyanate (FITC), Alexa Fluor 488, PE,
peridinin chlorophyll protein-Cy5.5 (PerCP-Cy5.5), PE-Cy7, APC, APC-Cy7, APC-eFluor780,
Brilliant Violet 421, eFluor450, and Alexa Fluor 647 conjugates. Antibodies were purified from
hybridoma supernatants using standard procedures or were purchased from eBioscience, BD
Biosciences (San Jose, CA, USA), BioLegend (San Diego, CA, USA), or R&D Systems (Minne-
apolis, MN, USA). For intracellular stainings, an intracellular staining buffer set and a Foxp3/
transcription factor staining buffer set (both eBioscience) were used according to the manufac-
turer’s protocol. RNA flow cytometry was performed using the PrimeFlow system (Thermo
Fisher Scientific). Cells were stained with Nr4a1-AF647. Samples were acquired on LSRII (BD
Biosciences) cytometers and sorted on a FACS Aria II (BD Biosciences). Data were analyzed
with FlowJo software, v.9.4.9 (Tree Star, Ashland, OR, USA). For analysis, dead cells and debris
were excluded by gating of forward and side scatter. Sorted cells were of 98% or higher purity,
as determined by reanalysis.
In vivo Treg-cell induction assay
RTEs depleted of Treg cells were sorted as Rag1GFP+CD4+CD8α−CD25− from the spleens of
Foxp3hCD2 × Rag1GFP × miR-181a/b-1−/− and Foxp3hCD2 × Rag1GFP × miR-181a/b-1+/− mice.
5 × 105 cells were injected into the lateral tail vein of lymphopenic IL-7Rα−/− (CD45.1) recipi-
ents. Spleens, peripheral lymph nodes (pLNs: inguinal, brachial, axiliary, and cervical), and
mLN were analyzed for the induction of Foxp3 within donor population (CD45.2) 28 days later.
In vitro suppression assay
Splenic antigen-presenting cells (CD45.1+) were purified using sheep-anti-rat magnetic beads
and depletion of CD19, CD3, NK1.1, and Gr-1–positive cells as described above. Cells were
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plated on a U-bottom–shaped 96-well plate coated with αCD3 antibody (17A2, 10 μg/ml) at 4
˚C, overnight, at the density 1 × 104 cells/100 μl/well. Next, they were loaded with OVA323–339
peptide (2 μg/ml; AnaSpec, Fremont, CA, USA) for 45 min at 37 ˚C and washed 3 times to
remove unbound peptide. Naïve, CD4+ OT-II cells (CD45.1/2+) were purified using a CD4+T
cell negative depletion kit (Invitrogen). Cells were further labeled with 1 μM CFSE (Molecular
Probes, Eugene, OR, USA) for 10 min at 37 ˚C and washed twice. They were added to peptide-
loaded antigen-presenting cells at a density of 1 × 105 cells/well (antigen-presenting cell/OT-II
ratio 1:10). Treg cells (CD45.2+) were sorted as CD4+CD25+ cells from spleens of miR-181a/b-
1+/− and miR-181a/b-1−/− mice (purity always >98%), and their graded concentrations were
added to antigen-presenting cell/OT-II cocultures in the presence of murine IL-2 (100 U/ml,
PeproTech). Assay was analyzed after 48–60 h by flow cytometry.
In vivo suppression assay
To analyze the function of Treg cells in vivo, sorted populations of naïve CD45.1+ (1 × 105 to
4 × 105 cells) together with CD45.2+ miR-181a/b-1+/− or miR-181a/b-1−/− Treg cells were
injected intravenously into Rag1−/− recipients and analyzed after 14 days.
TCR sequencing
Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany) from 1 × 105
sorted thymic CD3+CD4+CD25+ miR-181a/b-1+/− or miR-181a/b-1−/− Treg cells and 4 × 105
sorted splenic CD3+CD4+CD25+ miR-181a/b-1+/− or miR-181a/b-1−/− Treg cells. Purity was
above 98% as determined by reanalysis. Four independent sorts were performed (pooled 4–5
mice/genotype), and so were 2 independent sequencing experiments. cDNA templates were
synthesized using SuperScript II reverse transcriptase (Invitrogen) according to the manufac-
turer’s recommendation. To generate template libraries of rearranged TCR CDR3 regions
from Treg-cell cDNA for the Genome Sequencer FLX system (454 sequencing; Roche, Basel,
Switzerland), we used primers spanning the variable region between constant Cα and V ele-
ments of the Vα8 family (comprising TRAV12-1�01, TRAV12-1�03, TRAV12-1�04, TRAV12-
1�05, TRAV12D-2�01, TRAV12D-2�02, TRAV12D-2�03, TRAV12D-2�04, TRAV12D-2�05,
TRAV12D-3�01, TRAV12D-3�02, and TRAV12D-3�03) [50]. Forward and reverse primers
contained at their 50 ends the universal adapter sequences and a multiplex identifier (MID),
respectively. Amplicons were purified by agarose gel electrophoresis and QIAquick Gel Extrac-
tion Kit (Qiagen) and quantified by Quant-iT dsDNA HS Assay Kit (Invitrogen). Single PCR
amplicon molecules were immobilized onto DNA capture beads within an oil–water emulsion
to enable clonal amplification in a second PCR process with universal primers. The emulsion
was then disrupted, and isolated beads were loaded onto PicoTiterPlates. Sequencing reactions
were performed by ultradeep 454 pyrosequencing on the Genome Sequencer FLX system
(Roche). Productive rearrangements and CDR3α regions were defined by comparing nucleo-
tide sequences to the reference sequences from IMGT, the international ImMunoGeneTics
information system (http://www.imgt.org) [51]. Rearrangements were analyzed and CDR3α
regions were defined using IMGT/HighV-QUEST [52].
Confocal microscopy
CD4+ T cells were purified from spleens and pLN of miR-181a/b-1+/− and miR-181a/b-1−/−
mice using CD4+ T-cell negative isolation kit (Dynal, Invitrogen). Next, cells were plated on
glass coverslips (Assistent, 0.13–0.16 mm, Thermo Fisher Scientific) coated with poly-L-lysine
(Sigma Aldrich) or Histogrip (Invitrogen) for 2 h at 37 ˚C. In some experiments, glass cover-
slips were additionally coated with αCD3 antibody (10 μg/ml, 17A2) and αCD28 antibody
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(10 μg/ml, 37.51). After 2 h, cells were fixed in 3% (v/v) electron-microscopy–grade PFA (Elec-
tron Microscopy Sciences). CTLA-4, Foxp3, LAMP2, EEA1, GM130, and Rab11 were stained
using indirect immunofluorescence. The following primary antibodies were used: purified α-
mouse CTLA-4 (UC10-4F10-11, BD Biosciences) labeled with DyLight650 antibody labeling
kit (Pierce, Thermo Fisher Scientific) according to the manufacturer’s protocol, Alexa-
Fluor488-labeled rat-α-mouse Foxp3 (MF23, BD Biosciences), purified rat-α-mouse LAMP2
(Hybridoma Bank), α-mouse EEA-1 (14/EEA1, BD Biosciences), α-mouse GM130 (35/
GM130, BD Biosciences), and α-mouse Rab11 (D4F5, Cell Signaling, Danvers, MA). The fol-
lowing secondary antibodies were used, all conjugated to AlexaFluor488 (all Molecular
Probes): mouse-α-rat, rat-α-mouse, and goat-α-rabbit. Nuclear staining was performed using
DAPI (Molecular Probes). Coverslips were mounted on glass slides using aqueous mounting
medium (DakoCytomation, Glostrup, Denmark). Samples were analyzed by confocal fluores-
cent microscopy using a Leica SP5 inverted microscope (Leica Microsystems, Wetzlar, Ger-
many). During imaging, a single focal plane was monitored in x-y-z scanning mode using
63×/1.4–0.6 NA oil HCX PL APO lambda blue DIC oil objective, UV laser (405 nm), argon
laser (488 nm), diode-pumped solid-state (DPSS) laser (561 nm), and helium–neon (HeNe)
laser (633 nm) at a scanner frequency of 400 Hz, line averaging 4. In order to avoid fluores-
cence overlap, sequential scans were performed. Images were analyzed using LAS AF Lite
(Leica Microsystems) and ImageJ software. Quantification of fluorescence intensity and image
analysis was performed using ImageJ software.
Inhibition of lysosomal degradation in Treg cells
CD4+CD25+ Treg cells were enriched from spleens and LNs of miR-181a/b-1+/− or miR-181a/
b-1−/− mice using a MACS isolation kit (Miltenyi Biotec, Bergisch Gladbach, Germany). Cells
were incubated in the absence or presence of 50 nM bafilomycin (InvivoGen, San Diego, CA,
USA) and collected after 30, 60, 120, and 180 min. Samples were stained with αCD4, αCD25,
and αhCD2 (Foxp3) antibodies and intracellularly for CTLA-4. For intracellular stainings, the
Foxp3/transcription factor staining buffer set (eBioscience) was used according to the manu-
facturer’s protocol. Samples were acquired on LSRII (BD Biosciences). Data were analyzed
with FlowJo software, v.9.4.9 (Tree Star). For analysis, dead cells and debris were excluded via
staining with Zombie Aqua reagent (BioLegend) prior to fixation and permabilization of cells.
Microarrays
RNA isolation, cDNA preparation, and DNA microarray analysis of gene expression were per-
formed at the Microarray Genechip Facility of the University of Tübingen (MFT Services).
Fluorescent images of hybridized microarrays (MOE-430 version 2.0; Affymetrix, Santa Clara,
CA, USA) were obtained using an Affymetrix Genechip Scanner. Microarray data were ana-
lyzed using BioConductor Suite 2.1 software. All samples were repeated two times with indi-
vidually sorted cells and averaged.
Small RNAseq
Treg cells (1 × 105) sorted from 3 pooled WT and miR-181a/b-1−/− thymi were stored in RNA-
protect Cell Reagent (Qiagen). Small RNAseq was performed by Admera Health (South Plain-
field, NJ, USA) using the SMARTer smRNA-Seq Kit (Takara, Kusatsu, Japan). Adapters were
trimmed with Flexbar 3.4, and rRNA was removed using Bowtie 2. The remaining reads were
aligned using STAR aligner and counted using HTSeq. Differential expression analysis was
performed in R using the DESeq2 package. Three biological replicates per genotype were
analyzed.
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Luciferase assay
Part of the CTLA-4 coding sequence (CTLA-4WT, 294 bp) and a version devoid of the putative
miR-181a binding site (CTLA-4del, 271 bp) were synthesized by GeneArt (Regensburg, Ger-
many) and cloned into PsiCheck2.0 Vector (Promega, Madison, WI, USA). 3T3 cells overex-
pressing murine miR-181a or ctrl cells were established by retroviral transduction and sorted
to 100% purity (GFP reporter). Viral particles were produced in HEK293T cells by co-transfec-
tion with pCLEco (coexpressing MLV gag, pol, and env) and the plasmids MDH1-PGK-
GFP_2.0 (Addgene plasmid #11375) or MDH1-miR-181a-1-PGK-GFP (Addgene plasmid
#11376), which were gifts from Chang-Zheng Chen [53]. 3T3 cells were cultured in complete
DMEM (Life Technologies, Carlsbad, CA, USA) (10% FCS, 100 U PenStrep, 1 mM Na-pyru-
vate, 25 μg/mL Geneticin [Life Technologies]). 250,000 cells were electroporated with 0.1 μg
of PsiCheck2.0 (250 V, 950 μF, Biorad Gene Pulser II) and cultured for 24 h on 6-well
plates. Dual-Luciferase Reporter (DLR) assays (Promega) were conducted according to the
manufacturer’s instructions. Luciferase activity was measured using Lumat LB 9507 machine
(Berthold).
qRT-PCR
RNA was prepared using the miRNeasy Kit according to the manufacturer’s instructions (Qia-
gen). RT reaction was performed using TaqMan MicroRNA Reverse Transcription Kit
(Applied Biosystems, Thermo Fisher Scientific, Waltham, MA, USA) and miRNA-specific
primers according to the manufacturer’s protocol. Quantitative RT-PCR analysis of miRNA
expression was carried out using the following Taqman probes: hsa-miR-181a, TM: 000480;
mmu-miR-15b, TM: 000390; mmu-miR-150-5p, TM: 000473; mmu-miR-342, TM: 002260;
mmu-let-7g-5p, TM: 002282 (Applied Biosystems). Fold differences were calculated using the
ΔCt method normalized to snoRNA412 as housekeeping miRNA gene (Applied Biosystems,
TM: 001243).
Statistical analyses
All analyses were performed using GraphPad Prism software. Data are represented as
mean ± SD. Statistical analyses of significance were performed using unpaired or paired Stu-
dent’s t test, multiple t test, or two-way ANOVA with Bonferroni post t test or Sidak’s multiple
comparison test.
Supporting information
S1 Fig. Early development of Treg cells in the absence of miR-181a/b-1. (A) Competitive
BM chimeras. BM cells from miR-181a/b-1+/− (het) or miR-181a/b-1−/− (KO) (both CD45.2)
were mixed in a 1:1 ratio with competitor WT BM cells (CD45.1/2) and injected into lethally
irradiated WT recipients (CD45.1). Chimeras were analyzed 12 weeks later for the generation
of CD4−CD8α− (DN), CD4+CD8α+ (DP), and CD4+CD8α− (CD4+SP) cells in the thymus.
Plots are representative of 2 independent experiments with n = 8 for each genotype. Graph
shows ratio of cells within test versus competitor populations. Each data point represents an
individual mouse. (B) FACS analysis of thymi from InduRag1 mice sufficient and deficient
for miR-181a/b-1, 7 days after induction of Rag1 expression. (C) Frequencies of tTreg cells
(TCRβ+CD4+CD25+Foxp3+), their precursors TCRβ+CD4+CD25−Foxp3+ (Ia), and
TCRβ+CD4+CD25+Foxp3− (Ib) on day 7 after initial induction of Rag1 expression in
InduRag1 mice sufficient and deficient for miR-181a/b-1. (D) FACS analysis of CD4 T-cell
selection, 7 days after Rag1 induction in InduRag1 mice. Depicted data are from 2
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independent experiments, with n = 1–4 for each genotype and time point analyzed. Numerical
values are available in S1 Data. BM, bone marrow; CD, cluster of differentiation; DN, double
negative; DP, double positive; FACS, fluorescence-activated cell scan; Foxp3, forkhead
box protein P3; InduRag1, inducible recombination-activating gene 1; KO, knockout; miR-
181, microRNA-181; prec, precursor; Rag1, recombination-activating gene 1; SP, single posi-
tive; Treg cell, regulatory T cell; tTreg cell, thymic Treg cell; WT, wild type.
(JPG)
S2 Fig. miR-181a/b-1 deficiency impairs generation of Treg cells in the thymus and does
not influence their peripheral induction from naïve T cells. (A) Plots show gating strategy
to discriminate newly generated tTreg cells (Foxp3hCD2+ cells positive for Rag1GFP) and the
population consisting of peripheral immigrants and thymus-residing mature Treg cells
(Foxp3hCD2+GFP− Treg cells). Representative plots of 5 independent experiments are shown.
Right panel, quantification; each data point represents one mouse. (B) Frequencies of RTEs
(Rag1GFP+CD4+CD25−) in spleens of miR-181a/b-1+/− and miR-181a/b-1−/− mice, left panel.
Frequencies of Treg-cell RTEs (Rag1GFP+CD4+Foxp3hCD2+) in spleens of miR-181a/b-1+/−
and miR-181a/b-1−/− mice, right panel. (C) De novo induction of Treg cells is not enhanced in
the absence of miR-181a/b-1. RTEs (Rag1GFP+CD4+CD25−) were sorted from spleens of
Rag1GFP/WT × miR-181a/b-1–sufficient and deficient mice (CD45.1+/CD45.2+ or CD45.2+)
and injected into lymphopenic Il7ra−/− recipients (CD45.1). Generation of Treg cells within
donor cells was analyzed after 28 days. Plots are representative of 2 independent experiments,
n = 3–4. Graphs show frequencies of CD25+Foxp3+ cells generated within donor TCRβ+CD4+
cells in spleen, pLNs, and mLNs. Statistical analysis was performed using unpaired Student’s t
test. Numerical values are available in S1 Data. CD, cluster of differentiation; Foxp3, forkhead
box protein P3; GFP, green fluorescent protein; hCD2, human CD2; Il7r, interleukin-7 recep-
tor alpha; miR-181, microRNA-181; mLN, mesenteric lymph node; pLN, peripheral lymph
node; Rag1, recombination activating gene 1; RTE, recent thymic emigrant; TCR, T-cell recep-
tor; Treg cell, regulatory T cell; tTreg cell, thymic Treg cell.
(JPG)
S3 Fig. Peripheral expansion of miR-181a/b-1–deficient Treg cells compensates for their
impaired development. (A) TCR repertoire of miR-181a/b-1–deficient tTreg (upper graph)
and splenic Treg (lower graph) cells. Vα8–Cα amplicons were amplified from cDNA of Treg
cells before high-throughput sequencing. Frequencies of individual Vα–Cα sequences detected
in miR-181a/b-1+/− (black) and miR-181a/b-1−/− (red) Treg cells. The copy number of Vα–Cα
sequences is displayed against the number of individual nucleotide sequences. Data are derived
from 2 independent experiments with samples sorted from n = 4–6 mice (pool). Numerical
values are available in S1 Data. cDNA, complementary DNA; miR-181, microRNA-181; TCR,
T-cell receptor; Treg cell, regulatory T cell; tTreg cell, thymic Treg cell.
(JPG)
S4 Fig. Flow-cytometry analysis of miR-181a/b-1–deficient Treg cells. Selected surface and
intracellular proteins expressed by tTreg (A), splenic Treg (B), and LN-resident Treg (C) cells.
Representative histograms and plots from 2 independent experiments (n = 6–9 for each geno-
type) are depicted. Numbers indicate average MFI or frequencies of positive cells, ±SD.
Numerical values are available in S1 Data. LN, lymph node; MFI, mean fluorescence intensity;
miR-181, microRNA-181; Treg cell, regulatory T cell; tTreg cell, thymic Treg cell.
(JPG)
S5 Fig. No evidence for post-transcriptional regulation of CTLA-4 by miR-181a/b-1 or
miRNAs down-regulated in miR-181a/b-1–deficient Treg cells. (A) Predicted base-pairing
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of miR-181a with the target sequence in the cds of CTLA-4. The seed sequence in the miRNA
and the complementary sequence in the cds are displayed in bold letters. Number indicates the
position within the CTLA-4 cds. (B) Relative luciferase intensities of CTLA-4 coding sequence
(CTLA-4WT) and cds lacking 23 bp of the predicted miR-181a binding site (CTLA-4del) nor-
malized to empty luciferase vector ctrl in 3T3 cells overexpressing miR-181a (miR-181a) or
respective ctrls. Bars represent mean of>20 experiments and SD. (C) Small RNAseq volcano
plot of differentially regulated miRNAs in miR-181a/b-1−/− compared to WT tTreg cells. (D)
qRT-PCR analysis of differentially regulated miRNAs identified in small RNAseq analysis in
sorted tTreg cell (left column) and splenic Treg cell populations (right column). Data from 3
independent experiments, with n = 2–7 (pool) for each genotype. Expression of each miRNA
was normalized to the expression of housekeeping small RNA, snoR412. ΔΔCT values are dis-
played on the graph. Numerical values are available in S1 Data. cds, coding sequence; CTLA-4,
cytotoxic T-lymphocyte–associated protein 4; ctrl, control; miRNA, microRNA; miR-181,
microRNA-181; qRT-PCR, quantitative reverse-transcription PCR; RNAseq, RNA sequenc-
ing; snoR412, small nucleolar RNA 412; Treg cell, regulatory T cell; tTreg cell, thymic Treg
cell; WT, wild type.
(JPG)
S6 Fig. miR-181a/b-1–deficient Treg cells are more suppressive in vitro. (A) Production of
cytokines by splenic CD8+ T cells after stimulation with PMA/ionomycin. Graphs represent
quantification of the data from 2 independent experiments, n = 4–5 for each genotype. (B) In
vitro suppression assay. Splenic antigen-presenting cells were loaded with OVA323–339 peptide
and cocultured with OT-II cells in the presence of graded numbers of sorted Treg cells from
spleens of miR-181a/b-1+/− and miR-181a/b-1−/− mice. Graph shows percent of suppression
calculated as follows: The number of CFSElow OT-II cells (dividing) in the absence of Treg
cells (ctrl sample) was set as 100%. Further, numbers of CFSElow OT-II cells that survived in
the presence of Treg cells were transformed to frequencies according to ctrl sample, and this
number was subtracted from 100%, which gave the percent of suppression exhibited by a
given number of Treg cells. Data are representative of 4 independent experiments, with
n = 7–8 for Treg cell donor mice. Numerical values are available in S1 Data. CFSE, carboxy-
fluorescein succinimidyl ester; ctrl, control; miR-181, microRNA-181; OT-II, ovalbumin-spe-
cific MHC class II-restricted alpha beta TCR; OVA, chicken ovalbumin; PMA, phorbol
12-myristate 13-acetate; Treg cell, regulatory T cell.
(JPG)
S1 Data. Numerical values for graphical representations of data shown in all figures.
(XLSX)
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